Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies

Rayson, D.; Richel, D.; Chia, S.; Jackisch, C.; Van Der Vegt, S.; Suter, T. (2008). Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies. Annals of oncology, 19(9), pp. 1530-1539. Oxford University Press 10.1093/annonc/mdn292

[img]
Preview
Text
mdn292.pdf - Published Version
Available under License Publisher holds Copyright.

Download (133kB) | Preview

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Suter, Thomas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Markus Müller

Date Deposited:

27 Sep 2018 11:42

Last Modified:

25 Oct 2019 01:39

Publisher DOI:

10.1093/annonc/mdn292

BORIS DOI:

10.7892/boris.115569

URI:

https://boris.unibe.ch/id/eprint/115569

Actions (login required)

Edit item Edit item
Provide Feedback